From Cancer to Pain Target by Automated Selectivity Inversion of a Clinical Candidate
Author:
Affiliation:
1. BioMed X Innovation Center, Im Neuenheimer Feld 515, 69120 Heidelberg, Germany
Funder
BioMed X Innovation Center
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Molecular Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.8b00140
Reference42 articles.
1. Kinase Inhibitor Profiling Reveals Unexpected Opportunities to Inhibit Disease-Associated Mutant Kinases
2. Computational and Practical Aspects of Drug Repositioning
3. Navigating the kinome
4. The ChEMBL bioactivity database: an update
5. Comprehensive analysis of kinase inhibitor selectivity
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Structural Optimization and Structure–Activity Relationship Studies of 6,6-Dimethyl-4-(phenylamino)-6H-pyrimido[5,4-b][1,4]oxazin-7(8H)-one Derivatives as A New Class of Potent Inhibitors of Pan-Trk and Their Drug-Resistant Mutants;Journal of Medicinal Chemistry;2022-01-26
2. Fragment Hotspot Mapping to Identify Selectivity-Determining Regions between Related Proteins;Journal of Chemical Information and Modeling;2022-01-12
3. Recent Advances in Pain Management: Relevant Protein Kinases and Their Inhibitors;Molecules;2021-05-04
4. Cinnamide derived pyrimidine-benzimidazole hybrids as tubulin inhibitors: Synthesis, in silico and cell growth inhibition studies;Bioorganic Chemistry;2021-05
5. Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases;Journal of Medicinal Chemistry;2021-01-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3